• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然产物作为特应性皮炎治疗中芳烃受体信号的调节剂

Natural Products as Modulators of Aryl Hydrocarbon Receptor Signaling in Atopic Dermatitis Management.

作者信息

Lee Jangho, Choi Hyo-Kyoung, Shin Hee Soon, Kim Gun-Dong

机构信息

Division of Food Functionality Research, Korea Food Research Institute (KFRI), Wanju 55365, Republic of Korea.

Department of Food Biotechnology, Korea University of Science and Technology (UST), Daejeon 34113, Republic of Korea.

出版信息

Molecules. 2024 Dec 17;29(24):5951. doi: 10.3390/molecules29245951.

DOI:10.3390/molecules29245951
PMID:39770040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11678720/
Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by immune dysregulation, skin barrier dysfunction, and a significant patient burden. Recent studies have highlighted the aryl hydrocarbon receptor (AhR) as a promising therapeutic target for AD management because of its pivotal role in modulating immune responses and maintaining skin barrier integrity. The dysfunction of the AhR pathway has been linked to AD pathogenesis, emphasizing the need for therapies that can restore its regulatory functions. Natural products have emerged as potential modulators of the AhR and are effective and safe alternatives to conventional treatments. Compounds such as curcumin, resveratrol, quercetin, and microbial metabolites have demonstrated the ability to activate AhR, reduce inflammation, and promote skin barrier function. These natural agents have fewer side effects and enhance patient compliance compared with conventional therapies, making them attractive candidates for long-term AD management. The integration of natural products targeting the AhR pathway provides a multifaceted approach that alleviates symptoms, addresses underlying disease mechanisms, and promotes sustainable improvements in skin health. This review highlights the therapeutic potential of natural AhR modulators and their potential roles in enhancing patient outcomes through novel integrative treatment strategies.

摘要

特应性皮炎(AD)是一种慢性炎症性皮肤病,其特征为免疫失调、皮肤屏障功能障碍以及给患者带来沉重负担。最近的研究强调芳烃受体(AhR)作为AD治疗的一个有前景的靶点,因为它在调节免疫反应和维持皮肤屏障完整性方面起着关键作用。AhR信号通路功能障碍与AD发病机制相关,这凸显了对能够恢复其调节功能的疗法的需求。天然产物已成为AhR的潜在调节剂,并且是传统治疗的有效且安全的替代方案。姜黄素、白藜芦醇、槲皮素等化合物以及微生物代谢产物已证明具有激活AhR、减轻炎症和促进皮肤屏障功能的能力。与传统疗法相比,这些天然药物副作用更少,能提高患者的依从性,使其成为AD长期管理的有吸引力的候选药物。针对AhR信号通路的天然产物整合提供了一种多方面的方法,可缓解症状、解决潜在疾病机制并促进皮肤健康的可持续改善。本综述强调了天然AhR调节剂的治疗潜力及其通过新型综合治疗策略改善患者预后的潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9846/11678720/110531cdcd6d/molecules-29-05951-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9846/11678720/5c5e36ccf413/molecules-29-05951-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9846/11678720/0d96b1b16d90/molecules-29-05951-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9846/11678720/110531cdcd6d/molecules-29-05951-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9846/11678720/5c5e36ccf413/molecules-29-05951-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9846/11678720/0d96b1b16d90/molecules-29-05951-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9846/11678720/110531cdcd6d/molecules-29-05951-g003.jpg

相似文献

1
Natural Products as Modulators of Aryl Hydrocarbon Receptor Signaling in Atopic Dermatitis Management.天然产物作为特应性皮炎治疗中芳烃受体信号的调节剂
Molecules. 2024 Dec 17;29(24):5951. doi: 10.3390/molecules29245951.
2
Diosmin restores the skin barrier by targeting the aryl hydrocarbon receptor in atopic dermatitis.地奥司明通过靶向特应性皮炎中的芳香烃受体来修复皮肤屏障。
Phytomedicine. 2021 Jan;81:153418. doi: 10.1016/j.phymed.2020.153418. Epub 2020 Nov 25.
3
Aryl hydrocarbon receptor/nuclear factor E2-related factor 2 (AHR/NRF2) signalling: A novel therapeutic target for atopic dermatitis.芳香烃受体/核因子 E2 相关因子 2(AHR/NRF2)信号通路:特应性皮炎的新治疗靶点。
Exp Dermatol. 2022 Apr;31(4):485-497. doi: 10.1111/exd.14541. Epub 2022 Mar 1.
4
GDU-952, a novel AhR agonist ameliorates skin barrier abnormalities and immune dysfunction in DNFB-induced atopic dermatitis in mice.GDU-952,一种新型 AhR 激动剂,可改善 DNFB 诱导的小鼠特应性皮炎的皮肤屏障异常和免疫功能障碍。
Biochem Pharmacol. 2023 Nov;217:115835. doi: 10.1016/j.bcp.2023.115835. Epub 2023 Sep 29.
5
A tryptophan metabolite of the skin microbiota attenuates inflammation in patients with atopic dermatitis through the aryl hydrocarbon receptor.皮肤微生物组色氨酸代谢物通过芳香烃受体减轻特应性皮炎患者的炎症。
J Allergy Clin Immunol. 2019 Jun;143(6):2108-2119.e12. doi: 10.1016/j.jaci.2018.11.036. Epub 2018 Dec 20.
6
The AhR-Ovol1-Id1 regulatory axis in keratinocytes promotes epidermal and immune homeostasis in atopic dermatitis-like skin inflammation.角质形成细胞中的AhR-Ovol1-Id1调控轴在特应性皮炎样皮肤炎症中促进表皮和免疫稳态。
Cell Mol Immunol. 2025 Mar;22(3):300-315. doi: 10.1038/s41423-025-01264-z. Epub 2025 Feb 13.
7
IL-24 Negatively Regulates Keratinocyte Differentiation Induced by Tapinarof, an Aryl Hydrocarbon Receptor Modulator: Implication in the Treatment of Atopic Dermatitis.IL-24 负调控芳香烃受体调节剂他卡西醇诱导的角质形成细胞分化:在特应性皮炎治疗中的意义。
Int J Mol Sci. 2020 Dec 10;21(24):9412. doi: 10.3390/ijms21249412.
8
The Aryl Hydrocarbon Receptor (AHR): Peacekeeper of the Skin.芳烃受体(AHR):皮肤的守护者。
Int J Mol Sci. 2025 Feb 14;26(4):1618. doi: 10.3390/ijms26041618.
9
Itching for innovation: the role of aryl hydrocarbon receptor agonists as a future therapy for atopic dermatitis.渴望创新:芳烃受体激动剂作为特应性皮炎未来治疗方法的作用。
Clin Exp Dermatol. 2025 Mar 26;50(4):747-754. doi: 10.1093/ced/llae502.
10
Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis.芳香烃受体在特应性皮炎和银屑病中的作用。
Int J Mol Sci. 2019 Oct 31;20(21):5424. doi: 10.3390/ijms20215424.

本文引用的文献

1
Activation of the aryl hydrocarbon receptor via indole derivatives is a common feature in skin bacterial isolates.芳香烃受体的激活通过吲哚衍生物是在皮肤细菌分离株中的一个共同特征。
J Appl Microbiol. 2024 Nov 4;135(11). doi: 10.1093/jambio/lxae273.
2
Biologic and Small Molecule Therapy in Atopic Dermatitis.特应性皮炎的生物制剂和小分子疗法
Biomedicines. 2024 Aug 13;12(8):1841. doi: 10.3390/biomedicines12081841.
3
Pharmacological Trends in the Management of Atopic Dermatitis: A Comprehensive Review.特应性皮炎管理中的药理学趋势:全面综述
Cureus. 2024 Jul 11;16(7):e64302. doi: 10.7759/cureus.64302. eCollection 2024 Jul.
4
Exploring the Complexities of Atopic Dermatitis: Pathophysiological Mechanisms and Therapeutic Approaches.探索特应性皮炎的复杂性:病理生理机制与治疗方法
J Biotechnol Biomed. 2024;7(3):314-328. doi: 10.26502/jbb.2642-91280155. Epub 2024 Jul 17.
5
Neuroprotective effects of fermented blueberry and black rice against particulate matter 2.5 μm-induced inflammation and .发酵蓝莓和黑米对2.5微米颗粒物诱导的炎症的神经保护作用及……(原文此处不完整)
Drug Chem Toxicol. 2025 Jan;48(1):16-26. doi: 10.1080/01480545.2024.2367559. Epub 2024 Jul 22.
6
The Role of Quercetin as a Plant-Derived Bioactive Agent in Preventive Medicine and Treatment in Skin Disorders.槲皮素作为一种植物源生物活性物质在预防医学和皮肤疾病治疗中的作用。
Molecules. 2024 Jul 5;29(13):3206. doi: 10.3390/molecules29133206.
7
Recent Advances in Phytochemical-Based Topical Applications for the Management of Eczema: A Review.基于植物化学的湿疹局部治疗应用的最新进展:综述。
Int J Mol Sci. 2024 May 15;25(10):5375. doi: 10.3390/ijms25105375.
8
Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials.他卡西醇乳膏 1%,每日一次:在关键的 3 期 ADORING 试验中,对于 2 岁及以上的中重度特应性皮炎成人和儿童患者,具有显著疗效。
J Am Acad Dermatol. 2024 Sep;91(3):457-465. doi: 10.1016/j.jaad.2024.05.023. Epub 2024 May 20.
9
Role of aryl hydrocarbon receptors in infection and inflammation.芳基烃受体在感染和炎症中的作用。
Front Immunol. 2024 Apr 12;15:1367734. doi: 10.3389/fimmu.2024.1367734. eCollection 2024.
10
Biologic and small-molecule therapy for treating moderate to severe atopic dermatitis: Mechanistic considerations.治疗中重度特应性皮炎的生物制剂和小分子治疗药物:作用机制的考虑因素。
J Allergy Clin Immunol. 2024 Jul;154(1):20-30. doi: 10.1016/j.jaci.2024.04.009. Epub 2024 Apr 24.